Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farmila-Théa Farmaceutici is the Italian subsidiary of Laboratoires Théa, a leading independent European pharmaceutical group dedicated entirely to ophthalmology. The company specializes in the development and commercialization of a wide range of eye care products, including treatments for glaucoma, dry eye, infections, and allergies. Farmila-Théa is particularly known for its preservative-free technology, such as the ABAK system, which enhances patient safety and comfort by eliminating the need for harmful preservatives in chronic treatments. Based in Milan, the company serves as a key hub for the group's operations in the Italian market, providing both prescription drugs and over-the-counter ocular hygiene products. The firm maintains a strong focus on innovation in ocular surface health and surgical support. Through its integration with the global Théa network, it offers a comprehensive portfolio that addresses the needs of both ophthalmologists and patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Farmila-Théa Farmaceutici.